Searched for
ABBOTT HEALTHCARE PRIVATE LTD
Abbott introduces single-dose formulation of carbetocin in IndiaPPH, if left untreated, can result in complications like anaemia in the postpartum period or aggravate mental health problems including pos...
Ajay Piramal eyes $1 billion in contract pharma saleDeliberations are at an early stage, and Piramal Enterprises could still decide against pursuing a deal, the people said.
PE Funds, companies in race to acquire Kraft Heinz India’s consumer food unitComplan has about 8% market share in the Rs 6,000-7,000 crore market for malted food drink in the country. GSK’s Horlicks is the market lea...
Danone, HUL, KKR vie for GSK’s consumer businessAs per Monday’s market value, 72 per cent of GSK is worth around Rs 17,980 crore.
Mylan-Abbott deal gets CCI green signalThe CCI observed that "there is horizontal overlap" between the pharmaceutical products of Mylan and Abbott in India with respect to certai...
India Life Sciences Fund II raises Rs 865 crore in second fundThe oversubscription of India Life Sciences Fund II shows that investors are open to funds offering focused expertise in certain key indust...
Budget 2014: Rural healthcare set to get a fillipProviding impetus to rural healthcare, fifteen Model Rural Health Research have been proposed to be set up in the states.
- Shriram Transport gains on TPG’s stake sale talks; UBS downgrades
UBS is of the view that the stock is already pricing in an improving growth outlook and declining asset quality risks. The stock offers lim...
Shriram Transport Finance gains 2% on TPG’s stake sales talksSTFL surged over 2% following reports that Piramal Group is in advanced talks to buy TPG Capital's 20.27% stake in STFL.
- Pharmaceutical and healthcare sector to dominate M&As in 2012: Grant Thornton
India will see the largest number of M&As in pharmaceutical and healthcare sector this year despite regulations, according to Grant Thornto...
- Abbott, Dabur, GSK eye Jagdale’s energy drinks business
A line-up of MNC and Indian bidders are in the fray to acquire home grown electrolyte energy drinks business of Jagdale Healthcare.
- Piramal Healthcare subsidiary IndiaReit plans Rs 500 crore realty fund
IndiaReit Fund, a subsidiary of Piramal Healthcare, plans to raise a fund of 500 crore starting next month to invest in commercial property.
- Sanofi-Aventis in advanced talks to buy majority stake in Universal Medicare to scale up OTC biz in India
According to a person close to the deal, Sanofi-Aventis may buy a majority stake or key brands valuing the Indian company at around Rs 450 ...
- Piramal Healthcare posts Q1 net profit at Rs 89.23 crore
Piramal Healthcare on Tuesday said it has posted a net profit of Rs 89.23 crore for the quarter ended June 30, 2011.
- Paucity of takeover financing
This is a growing opportunity in banking and finance that will help Indian cos — to compete against deep pockets of MNCs — and small — to g...
- India Inc's M&A deal tally hits $25 bn in April-June
Driven by Reliance Infratel's USD 10.86 billion merger deal with GTL Infrastructure, the total value of merger and acquisition deals in the...
- M&A, PE deals more than double in 5 mths
Corporate merger & acquisitions and private equity transactions more than doubled in the first five months of the current calendar year, re...
MNC drug cos queing up in scores for Indian buysGlobal cos are looking at Indian pharma sector that is growing between 13% and 15% compared with 2-3% in West.
- Stocks to watch: ICICI Bank, Bharti Airtel, L&T, Dalmia Cement, Tata Power, Rel Infra, DLF, Ranbaxy
The telecom regulator's proposed new rules for the sector have been greeted with anger by mobile phone companies, which said the cure that ...
- SEC probes 9 transactions for insider trading violations
Many firms -- Pfizer, Merck, Wyeth, Eli Lilly and Abbott Laboratories, which are under investigation by SEC have significant presence in In...